Office of National Drug Control Policy Reauthorization Act of 2024
United States118th CongressHR-9598House of Representatives
Updated: Dec 9, 2024
Summary
No summary is available.
Bill texts
All available records shown.
Timeline
Considered as unfinished business. (consideration: CR H6395-6396)
House of Representatives
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 399 - 1 (Roll no. 485). (text: 12/4/2024 CR H6319-6322)
House of Representatives
View voteMotion to reconsider laid on the table Agreed to without objection.
House of Representatives
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Senate